2012 Economic Outlook - Report Highlights VIVUS, Inc. and Biogen Idec Inc.

HONG KONG -- (Marketwire) -- 02/03/12 -- Today, www.BrightonMarkets.com announced new reports highlighting VIVUS, Inc. (NASDAQ: VVUS) and Biogen Idec Inc. (NASDAQ: BIIB). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=VVUS&cob=BIIB.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experienced in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on VIVUS, Inc. for its current position within the healthcare industry. VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in development and commercialization of therapeutic drugs for large underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health. The full research report on VIVUS, Inc. (NASDAQ: VVUS) is available here: www.BrightonMarkets.com/index.php?coa=VVUS.

Brighton Markets has released research on Biogen Idec Inc. for its changing role within the healthcare industry. Biogen Idec Inc. (Biogen Idec) is a global biotechnology company focused on discovering, developing, manufacturing and marketing products for the treatment of neurological disorders and other serious diseases. The Company's products include AVONEX, TYSABRI, FUMADERM and RITUXAN. The full research report on Biogen Idec Inc. (NASDAQ: BIIB) is available here: www.BrightonMarkets.com/index.php?cob=BIIB.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.


Jean Barnes
Email Email Contact

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here